The CBD, with its full name “the cannabidiol”, is beginning to make itself known in the vape community. It is one of the most common cannabinoids present in cultivated hemp, i. e. in the plant “Cannabis sativa L” with its counterpart, THC.
Increasingly relayed in the newspapers, the interest in CBD is growing and raises many questions. In this article, we propose you to come back to the major questions posed by CBD through the scientific point of view of the French E-liquid Laboratory (LFEL).
FREQUENT AMALGAM BETWEEN CBD AND THC
The scientific studies carried out currently include more than a hundred cannabinoids, the most present being undoubtedly CBD and THC.
Hence the general confusion in the minds of consumers who do not know the specificities of each individual consumer.
In fact, there are many similarities between CBD and THC on the chemical structure first of all but especially on pharmacological and therapeutic properties such as analgesic and anti-inflammatory properties. Thus, if you are subject to repeated or unlucky migraines from a muscle tear, it would partially relieve the pain.
On the other hand, the differences are found in the side effects provided. In fact, CBD, unlike THC, has very few proven side effects. The euphoric effects and the sensation of gliding are attributed to THC. What you should therefore remember is simple: CBD will not provide you with psychotropic effects but will have a positive effect on your well-being.
CBD is still associated with the recreational use of smoked cannabis (therefore THC) even though it is not the same purpose, according to Jeremy Sorin, an engineer at LFEL.
The work to be carried out is above all pedagogical in order to provide accurate information on the effects of CBD and to radically cut it off from its assimilation with THC. In France in particular, this work is all the more necessary since the subject of cannabis is taboo. As a result, the CBD is dragging behind it a bad reputation which seems unjustified in view of the scientific evidence provided to better apprehend it.
THE REAL EFFECTS OF CBD ON THE HUMAN ORGANISM
CBD has antipsychotic, analgesic and anxiolytic properties mainly. It would make it possible to fight against depressive phases and regulate changing moods, for example, but also to combat anxiety and panic attacks. CBD also has sedative properties (sleep disorders), neuroprotective properties (fight against cell degeneration as is the case for Alzheimer’s disease or cancer) and antidystonic properties (muscle tone disorder). Less well known, it is also a good remedy for nausea and vomiting.
The important point to raise is also related to the fact that CBD would reduce withdrawal symptoms from addiction. This can be a valuable help for smoking cessation and nicotine withdrawal, the primary purpose of using the personal vaporizer.
CBD AND PERSONAL SPRAY: HOW TO USE IT?
Strictly speaking, it is not possible to apply a general rule regarding the correct dosage for each user. It will be a question of testing your sensitivity to the molecule to choose the e-liquid proportionate to your consumption.
In today’s market, CBD 100,300 and 600 mg vials per 10 mL are available.
Enovap’s “Hit Control” technology allows you to adjust the nicotine level according to the user’s needs, which vary during the day. In the same way as nicotine, CBD could be dosed in a totally personalized way with the double reservoir and would allow the right dosage to be identified.
In addition, other factors may come into play. The sensation may vary according to the type of material used (dripper or clearomiser). Concerning the type of e-liquid, it is recommended to use e-liquids composed of CBD powder which guarantee the absence of THC unlike those using hemp oil enriched with CBD which also contain components considered unfit for inhalation.
CBD has many therapeutic effects but divides the vape community on the image it brings.” Does CBD have a role to play in tobacco control? This will be the question that we will have to answer in order to establish a position with regard to our current products “, says Jean Moiroud, President of Fivape. Thus, its marketing and expansion at this time with a controversial legal status will most likely be restricted, particularly in the commercial approach, as demonstrated by the recent Kannavape trial. This French company was the initiator in the combination of CBD with the electronic cigarette on the land.